BDX Becton Dickinson & Co
- 237.220
- +5.500+2.37%
- 237.220
- 0.0000.00%
Becton Dickinson & Co News
Express News | BD: New Data Shows Some BD Needle-Free Connectors Showed Decreased Risk for CVC-IBO & (Clabsi)I
Becton Dickinson & Co To Go Ex-Dividend On September 9th, 2024 With 0.95 USD Dividend Per Share
How to Play the Market Now: The Case for Defensive Value Stocks
50 Stocks to Invest During the Bull Steepening – Part 1
Russell Companies With the Lowest Tax Rates Expected to Generate $1B in 2025 – GS
Edwards Completes Unit Sale to BD, Expands Stock Buyback
Becton, Dickinson and Company (NYSE:BDX) Looks Interesting, And It's About To Pay A Dividend
BD Completes Acquisition of Critical Care From Edwards Lifesciences
Barclays Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $312
Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?
U.S. to Restart Free COVID Test Program as Cases Spike
(BDX) - Analyzing Becton Dickinson's Short Interest
Least Shorted S&P 500 Stocks in July
The 20 Most Popular Mutual Fund Increases During 2Q - Goldman Sachs
Express News | Hhs: Recommend Health Care Providers Prioritize & Conserve BD Bactec Blood Culture Media Bottles per FDA's Recommendations
Express News | Hhs: Aware of Disruptions in the Availability of BD Bactec Blood Culture Media Bottles
Wells Fargo Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $280
Moderna Was the Most Shorted S&P 500 Healthcare Stock in July
Analyzing Becton, Dickinson and Company (BDX) Among Top Dividend Aristocrats of 2024
Argus Research Cuts Price Target on Becton, Dickinson to $290 From $300, Buy Rating Maintained
Analysis
Price Target
No Data
